$140.72
2.07% today
NYSE, Dec 06, 05:45 pm CET
ISIN
US00846U1016
Symbol
A
Sector
Industry

Agilent Technologies Stock price

$137.87
-2.54 1.81% 1M
+4.31 3.23% 6M
-1.16 0.83% YTD
+9.99 7.81% 1Y
-13.60 8.98% 3Y
+56.34 69.10% 5Y
+95.57 225.93% 10Y
NYSE, Closing price Thu, Dec 05 2024
-2.33 1.66%
ISIN
US00846U1016
Symbol
A
Sector
Industry

Key metrics

Market capitalization $39.61b
Enterprise Value $41.67b
P/E (TTM) P/E ratio 31.16
EV/FCF (TTM) EV/FCF 30.35
EV/Sales (TTM) EV/Sales 6.40
P/S ratio (TTM) P/S ratio 6.09
P/B ratio (TTM) P/B ratio 6.67
Dividend yield 0.68%
Last dividend (FY24) $0.94
Revenue growth (TTM) Revenue growth -4.73%
Revenue (TTM) Revenue $6.51b
EBIT (operating result TTM) EBIT $1.58b
Free Cash Flow (TTM) Free Cash Flow $1.37b
Cash position $1.33b
EPS (TTM) EPS $4.42
P/E forward 27.89
P/S forward 5.80
EV/Sales forward 6.10
Short interest 1.36%
Show more

Is Agilent Technologies a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,879 stocks worldwide.

Agilent Technologies Stock Analysis

Unlock Scores for Free

Analyst Opinions

21 Analysts have issued a Agilent Technologies forecast:

9x Buy
43%
11x Hold
52%
1x Sell
5%

Analyst Opinions

21 Analysts have issued a Agilent Technologies forecast:

Buy
43%
Hold
52%
Sell
5%

Financial data from Agilent Technologies

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Oct '24
+/-
%
6,510 6,510
5% 5%
100%
- Direct Costs 2,932 2,932
5% 5%
45%
3,766 3,766
1% 1%
58%
- Selling and Administrative Expenses 1,549 1,549
16% 16%
24%
- Research and Development Expense 453 453
6% 6%
7%
1,833 1,833
4% 4%
28%
- Depreciation and Amortization - -
-
-
EBIT (Operating Income) EBIT 1,576 1,576
4% 4%
24%
Net Profit 1,289 1,289
4% 4%
20%

In millions USD.

Don't miss a Thing! We will send you all news about Agilent Technologies directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Agilent Technologies Stock News

Positive
Seeking Alpha
10 days ago
I reiterate a “Buy” rating on Agilent Technologies, Inc. with a one-year target price of $150 per share, driven by strategic growth and market recovery. Agilent's acquisition of BIOVECTRA will enhance its CDMO business, focusing on oligonucleotides and CRISPR therapeutics, and expand service offerings in peptide synthesis. Agilent's FY25 guidance includes 2.5%-3.5% core revenue growth and 5.8% ...
Neutral
Seeking Alpha
11 days ago
Agilent Technologies, Inc. (NYSE:A ) Q4 2024 Results Conference Call November 25, 2024 4:30 PM ET Company Participants Parmeet Ahuja - Vice President, Investor Relations Padraig McDonnell - President and CEO Bob McMahon - Senior Vice President and CFO Simon May - President, Life Sciences and Diagnostic Markets Group Phil Binns - President, Life Sciences & Applied Markets Group Angelica Riemann ...
Negative
Reuters
11 days ago
Agilent forecast its annual profit below analysts' estimates on Monday, as a recovery is ongoing in the market for medical tools and equipment used in clinical studies, sending its shares down more than 2% after the bell.
More Agilent Technologies News

Company Profile

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics, and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that identify, quantify, and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics, as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service, and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Head office United States
CEO Padraig Mcdonnell
Founded 1999
Website www.agilent.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today